[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577122":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":32,"collaborators":7,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Alessandra Gambineri, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+390512144628","alessandra.gambineri@aosp.bo.it",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Bologna","40138","Italy","IT",{"type":25,"coordinates":26},"Point",[27,28],11.33875,44.49381,{"lat":28,"lon":27},[31],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100577122","characterization-of-hepatopathy-in-turner-syndrome-analysis-of-determinants-100577122",false,"NCT06794190","Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants","Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants in an Observational Study","Inclusion Criteria:\n\n* Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.\n* Age 18 years or older\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).","FEMALE","18 Years",{"count":44,"type":45},120,"ESTIMATED","OBSERVATIONAL","The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities.\n\nThus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.",[49],"Turner Syndrome","2025-01-24",{"date":52,"type":53},"2025-01-27","ACTUAL",{"date":55,"type":53},"2025-01-07",{"date":57,"type":45},"2026-01-07",{"name":5,"class":6},1]